MS bears no effect on certain pregnancy complications, stillbirth, or congenital deformationFebruary 5, 2021Multiple Sclerosis
FDA approves intramuscular administration for peginterferon beta-1a in MSFebruary 3, 2021Multiple Sclerosis
Is the EDSS an adequate outcome measure in secondary progressive MS trials?January 29, 2021Multiple Sclerosis
Neutrophil granulocyte markers may distinguish between demyelinating diseasesOctober 21, 2020Multiple Sclerosis
Women with MS may have increased subclinical disease activity during pregnancyOctober 1, 2020Multiple Sclerosis
Prior autoimmunity does not predict adverse events of alemtuzumabSeptember 24, 2020Multiple Sclerosis
